ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $715,417 | +21.2% | 131,269 | +49.3% | 0.00% | 0.0% |
| Q2 2023 | $590,131 | -70.7% | 87,948 | -61.4% | 0.00% | -50.0% |
| Q1 2023 | $2,010,847 | +126.5% | 227,729 | +96.0% | 0.00% | +100.0% |
| Q4 2022 | $887,630 | +112.4% | 116,182 | +98.0% | 0.00% | – |
| Q3 2022 | $418,000 | -66.9% | 58,684 | -62.4% | 0.00% | -100.0% |
| Q2 2022 | $1,264,000 | -31.1% | 156,184 | +18.1% | 0.00% | -50.0% |
| Q1 2022 | $1,835,000 | +98.8% | 132,203 | +593.3% | 0.00% | +100.0% |
| Q2 2020 | $923,000 | +12.4% | 19,068 | -30.6% | 0.00% | 0.0% |
| Q4 2019 | $821,000 | – | 27,456 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |